KYNTRA BIO, INC. Liabilities Assumed
KYNTRA BIO, INC. (KYNB) reported Liabilities Assumed of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2021-03-01
- KYNTRA BIO, INC. liabilities assumed for fiscal 2020 was $0.00.
- KYNTRA BIO, INC. liabilities assumed for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- KYNTRA BIO, INC. liabilities assumed for fiscal 2018 was $24.00K, a 31.43% decline from fiscal 2017.
- KYNTRA BIO, INC. liabilities assumed for fiscal 2017 was $35.00K.
| Period end | Liabilities Assumed 12 month |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 |
| 2018-12-31 | $24.00K 10-K · filed 2021-03-01 |
| 2017-12-31 | $35.00K 10-K · filed 2020-03-02 |
| 2016-12-31 | $0.00 10-K · filed 2019-02-27 |
| 2015-12-31 | $0.00 10-K · filed 2018-02-27 |
| 2014-12-31 | $974.00K 10-K · filed 2017-03-01 |
| 2013-12-31 | $0.00 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |